Who Supplies Bromhexine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Bromhexine exports, with 288+ registered manufacturers shipping to buyers across 109+ countries — yet a handful of companies dominate the shipments. UMAVIDA PHARMA PRIVATE LIMITED holds the largest share at 14.9% (export value: $2.4M). Close behind, EMCURE PHARMACEUTICALS LIMITED (8.2%, $1.3M). MAXFORD HEALTHCARE (5.8%, $950.0K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Bromhexine? Top Manufacturers & Their Buyers
Flow of Bromhexine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Bromhexine Supplier Network — Key Market Intelligence
The Bromhexine export market from India is led by UMAVIDA PHARMA PRIVATE LIMITED, which alone commands a 14.9% share, shipping $2.4M worth of product across 53 shipments. The second-largest exporter, EMCURE PHARMACEUTICALS LIMITED, contributes $1.3M (8.2%) to the overall market. Combined, the top two suppliers alone account for 23.1% of all Bromhexine exports, indicating a relatively concentrated supply base.
Across all 288 tracked manufacturers, the total Bromhexine export value stands at $16.3M from 1.9K shipments. The market average shipment value is $8.4K. The single largest buyer relationship in terms of trade value is PRINCE FARMA, LDA, receiving $2.2M worth of product.
The combined buyer network spans 18 named purchasing companies, including PRINCE FARMA, LDA, PRINCE FARMA, SA, PRINCE FARMA LDA POL, KHETAN COMPANY LIMITED, E.P.DIS and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1UMAVIDA PHARMA PRIVATE LIMITED
UMAVIDA PHARMA PRIVATE LIMITED is the first-largest Bromhexine exporter from India, with a market share of 14.9% and a total export value of $2.4M across 53 shipments. Their average shipment value of $45.7K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
UMAVIDA PHARMA PRIVATE LIMITED serves 5 named buyers in our database. PRINCE FARMA, LDA is the dominant customer, accounting for 92.4% of this supplier's tracked business. Top customers include:
• PRINCE FARMA, LDA — $2.2M across 49 shipments (92.4% of this supplier's total exports)
• PRINCE FARMA, LDA — $83.7K across 2 shipments (3.5% of this supplier's total exports)
• PRINCE FARMA, SA — $66.4K across 1 shipments (2.7% of this supplier's total exports)
• PRINCE FARMA, SA — $30.6K across 1 shipments (1.3% of this supplier's total exports)
• PRINCE FARMA LDA POL — $2.8K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: UMAVIDA PHARMA PRIVATE LIMITED's per-shipment value of $45.7K is 446% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
2EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the second-largest Bromhexine exporter from India, with a market share of 8.2% and a total export value of $1.3M across 119 shipments. Their average shipment value of $11.3K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. KHETAN COMPANY LIMITED is the dominant customer, accounting for 68.3% of this supplier's tracked business. Top customers include:
• KHETAN COMPANY LIMITED — $917.5K across 81 shipments (68.3% of this supplier's total exports)
• E.P.DIS — $135.2K across 12 shipments (10.1% of this supplier's total exports)
• KETAN COMPANY LIMITE — $123.1K across 11 shipments (9.2% of this supplier's total exports)
• HARLEY'S UGANDA LIMI — $88.3K across 8 shipments (6.6% of this supplier's total exports)
• FARMAMIR LLC — $79.1K across 7 shipments (5.9% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $11.3K is 35% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
3MAXFORD HEALTHCARE
MAXFORD HEALTHCARE is the third-largest Bromhexine exporter from India, with a market share of 5.8% and a total export value of $950.0K across 6 shipments. Their average shipment value of $158.3K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
MAXFORD HEALTHCARE serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YARATEB KHAVARMIANEH CO LTD — $396.0K across 3 shipments (41.7% of this supplier's total exports)
• YARATEB KHAVARMIANEH CO LTD — $198.0K across 1 shipments (20.8% of this supplier's total exports)
• YARA TEB KHAVARMIANEH CO LIMITED — $189.2K across 1 shipments (19.9% of this supplier's total exports)
• YARA TEB KHAVARMIANEH CO LIMITED — $166.8K across 1 shipments (17.6% of this supplier's total exports)
Key Insight: MAXFORD HEALTHCARE's per-shipment value of $158.3K is 1789% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
4AGIO PHARMACEUTICALS LIMITED
AGIO PHARMACEUTICALS LIMITED is the fourth-largest Bromhexine exporter from India, with a market share of 4.1% and a total export value of $676.0K across 41 shipments. Their average shipment value of $16.5K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
AGIO PHARMACEUTICALS LIMITED serves 3 named buyers in our database. AGIO RUS LLC is the dominant customer, accounting for 96.1% of this supplier's tracked business. Top customers include:
• AGIO RUS LLC — $649.6K across 39 shipments (96.1% of this supplier's total exports)
• NEMAN-FARM LLC — $16.9K across 1 shipments (2.5% of this supplier's total exports)
• AGIO HEALTHCARE INTE — $9.5K across 1 shipments (1.4% of this supplier's total exports)
Key Insight: AGIO PHARMACEUTICALS LIMITED's per-shipment value of $16.5K is 97% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
5LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the fifth-largest Bromhexine exporter from India, with a market share of 3.9% and a total export value of $643.5K across 12 shipments. Their average shipment value of $53.6K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 3 named buyers in our database. MAKANS LIMITED is the dominant customer, accounting for 99.3% of this supplier's tracked business. Top customers include:
• MAKANS LIMITED — $638.9K across 12 shipments (99.3% of this supplier's total exports)
• Metro Pharmaceutical — $3.4K across 0 shipments (0.5% of this supplier's total exports)
• LABORATORIO ZUZU CA. — $1.1K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $53.6K is 540% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
6J B CHEMICALS AND PHARMACEUTICALS LIMITED
J B CHEMICALS AND PHARMACEUTICALS LIMITED is the fifth-largest Bromhexine exporter from India, with a market share of 3.2% and a total export value of $514.3K across 48 shipments. Their average shipment value of $10.7K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
J B CHEMICALS AND PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• INOVA PHARMACEUTICALS (AUSTRALIA) P — $182.2K across 17 shipments (35.4% of this supplier's total exports)
• INOVA PHARMACEUTICALS (AUSTRALIA) P — $161.5K across 15 shipments (31.4% of this supplier's total exports)
• INOVA PHARMACEUTICALS (AUSTRALIA) P — $70.5K across 7 shipments (13.7% of this supplier's total exports)
• Y LIMITED 5 MILLNER — $62.4K across 6 shipments (12.1% of this supplier's total exports)
• INOVA PHARMACEUTICALS (AUSTRALIA) P — $37.7K across 4 shipments (7.3% of this supplier's total exports)
Key Insight: J B CHEMICALS AND PHARMACEUTICALS LIMITED's per-shipment value of $10.7K is 28% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Bromhexine Flows
Once Bromhexine leaves the manufacturing plants of companies like UMAVIDA PHARMA PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $16.3M. Angola absorbs the largest share at 19.0% ($3.1M), followed by Australia (9.3%) and Myanmar (8.0%).
In Angola — the top destination — named importers include PRINCE FARMA, LDA. In Australia, key buyers are INOVA PHARMACEUTICALS(AUSTRALIA) PT, MEDREICH AUSTRALIA PTY LTD, NOUMED PHARMACEUTICALS PTY LTD,.
This geographic spread reflects Bromhexine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Bromhexine Go? Top Importing Countries & Their Buyers
Trade flow of Bromhexine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Angola
Angola ranks as the first-largest destination for Bromhexine imports from India, with a total trade value of $3.1M across 30 shipments — representing a 19.0% share of all Bromhexine exports. The average shipment value of $103.0K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bromhexine importers in Angola: PRINCE FARMA, LDA is the largest buyer, accounting for 78.7% ($2.4M) of this market's total imports.
• PRINCE FARMA, LDA — $2.4M (78.7% of Angola's total)
Key Insight: Angola's per-shipment average of $103.0K (1129% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Angola is a key market for Bromhexine imports from India.
2Australia
Australia ranks as the second-largest destination for Bromhexine imports from India, with a total trade value of $1.5M across 94 shipments — representing a 9.3% share of all Bromhexine exports. The average shipment value of $16.2K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Bromhexine importers in Australia: INOVA PHARMACEUTICALS(AUSTRALIA) PT is the largest buyer, accounting for 25.0% ($380.4K) of this market's total imports.
• INOVA PHARMACEUTICALS(AUSTRALIA) PT — $380.4K (25.0% of Australia's total)
• MEDREICH AUSTRALIA PTY LTD — $215.3K (14.2% of Australia's total)
• NOUMED PHARMACEUTICALS PTY LTD, — $153.6K (10.1% of Australia's total)
Key Insight: Australia's per-shipment average of $16.2K (93% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Bromhexine imports from India.
3Myanmar
Myanmar ranks as the third-largest destination for Bromhexine imports from India, with a total trade value of $1.3M across 22 shipments — representing a 8.0% share of all Bromhexine exports. The average shipment value of $59.5K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bromhexine importers in Myanmar: KHETAN COMPANY LIMITED is the largest buyer, accounting for 70.0% ($917.5K) of this market's total imports.
• KHETAN COMPANY LIMITED — $917.5K (70.0% of Myanmar's total)
Key Insight: Myanmar's per-shipment average of $59.5K (611% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Bromhexine imports from India.
4Iran
Iran ranks as the fourth-largest destination for Bromhexine imports from India, with a total trade value of $964.6K across 4 shipments — representing a 5.9% share of all Bromhexine exports. The average shipment value of $241.2K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Bromhexine importers in Iran: YARATEB KHAVARMIANEH CO LTD is the largest buyer, accounting for 41.1% ($396.0K) of this market's total imports.
• YARATEB KHAVARMIANEH CO LTD — $396.0K (41.1% of Iran's total)
• YARA TEB KHAVARMIANEH CO LIMITED — $189.2K (19.6% of Iran's total)
Key Insight: Iran's per-shipment average of $241.2K (2778% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iran is a key market for Bromhexine imports from India.
5Russia
Russia ranks as the fifth-largest destination for Bromhexine imports from India, with a total trade value of $811.2K across 34 shipments — representing a 5.0% share of all Bromhexine exports. The average shipment value of $23.9K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bromhexine importers in Russia: AGIO RUS LLC is the largest buyer, accounting for 100.0% ($811.2K) of this market's total imports.
• AGIO RUS LLC — $811.2K (100.0% of Russia's total)
Key Insight: Russia's per-shipment average of $23.9K (185% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Bromhexine imports from India.
People Also Ask — Bromhexine Supplier & Trade Network
Who are the top suppliers of Bromhexine from India?+
Which companies buy Bromhexine from Indian manufacturers?+
Where does Bromhexine exported from India go?+
What is the market share of the top Bromhexine supplier from India?+
What is the average shipment value for Bromhexine exports from India?+
Is Bromhexine manufactured in India and exported globally?+
Which country imports the most Bromhexine from India?+
Who are the buyers of Bromhexine in Australia?+
How concentrated is the Bromhexine supplier market in India?+
How do I find verified buyers for Bromhexine in specific countries?+
Bromhexine Trade Network — Key Takeaways
- 1UMAVIDA PHARMA PRIVATE LIMITED is India's dominant Bromhexine exporter with a 14.9% market share and $2.4M in total exports — making it the single most important sourcing entity in this market.
- 2The top 288 suppliers collectively account for 40.2% of all tracked Bromhexine exports, with a combined trade value of $16.3M.
- 3Angola is the largest destination market, absorbing 19.0% of India's Bromhexine exports ($3.1M). Australia (9.3%) and Myanmar (8.0%) follow.
- 4With 1.9K total shipments averaging $8.4K each, the Bromhexine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include PRINCE FARMA, LDA, PRINCE FARMA, LDA, KHETAN COMPANY LIMITED, E.P.DIS — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 109 countries
Network value: $16.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bromhexine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Bromhexine.
- 2.Flow Mapping: 288 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,945 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 109 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,945 Verified Shipments
288 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists